Business
Uptick Newswire Hosts Blue Diamond Ventures, Inc. on the Stock Day Podcast to Discuss the Company’s Recent Acquisition of Harvest 360 Technologies LLC.
Uptick Newswire Hosts Blue Diamond Ventures, Inc. on the Stock Day Podcast to Discuss the Company’s Recent Acquisition of Harvest 360 Technologies LLC..
About this update from Blue Diamond Ventures, Inc.
[{"type":"text","content":"\nPHOENIX, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Blue Diamond Ventures, Inc. (OTC Pink: BLDV), an emerging Medical Cannabis BioTech player to join Stock Day host Everett Jolly to discuss the company’s recent acquisition of Harvest 360 Technologies LLC and what it means going forward.\n Jolly began the interview by asking Josh Alper (current BLDV CEO, moving to COO) and Todd Scattini (Current CEO H360, Moving into CEO of BLDV) to share their vision for the Company and explain how they entered the cannabis market. Scattini began by sharing that his vision for the military applications of cannabis brought him into the industry. Alper then brought listeners up-to-speed on the recent acquisition of Harvest 360 by Blue Diamond Ventures, Inc. and explained what it means for shareholders, “This was really an opportunity to merge these efforts together and provide a comprehensive package to the industry. Block45 Legal of Denver was key to the whole transaction as General Counsel for BLDV, and in addition, Clement Hayes, principle and founder of Block45 Legal, is a scientist and accomplish IP attorney that was an early supporter of H360.” Jolly then asked Scattini to expand on his new farm project, Cavalry Cannabis and how it will enable him to achieve his goal of using cannabis to help veterans. Scattini explained that the Kansas City based company, Cavalry Cannabis, will provide a platform for H360 to buildout innovations and medical cannabis applications that will be most helpful for the veteran population. These applications include symptoms of PTSD, depression anxiety, insomnia, pain relief, and opioid addiction. However, Scattini said the most important part of Cavalry Cannabis is to create a facility where they can conduct research on The Athena Protocol, H360’s strategy to mitigate and treat traumatic brain injury as well as CTE using non-impairing cannabinoids. “I do believe that we are on a new frontier of medicine, this is truly a paradigm shift in health and wellness.”, continued Scattini as he explained the Company’s goal to further explore this area of medicine and eventually gain the attention of the Department of Defense and the Veterans Administration. Scattini closed the interview by sharing his belief in the current paradigm shift of the me...